Computational protein design repurposed to explore enzyme vitality and help predict antibiotic resistance.
Monte Carlo
Proteus software
adaptive landscape flattening
dihydrofolate reductase
molecular mechanics
Journal
Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
03
2022
accepted:
19
12
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
In response to antibiotics that inhibit a bacterial enzyme, resistance mutations inevitably arise. Predicting them ahead of time would aid target selection and drug design. The simplest resistance mechanism would be to reduce antibiotic binding without sacrificing too much substrate binding. The property that reflects this is the enzyme "vitality", defined here as the difference between the inhibitor and substrate binding free energies. To predict such mutations, we borrow methodology from computational protein design. We use a Monte Carlo exploration of mutation space and vitality changes, allowing us to rank thousands of mutations and identify ones that might provide resistance through the simple mechanism considered. As an illustration, we chose dihydrofolate reductase, an essential enzyme targeted by several antibiotics. We simulated its complexes with the inhibitor trimethoprim and the substrate dihydrofolate. 20 active site positions were mutated, or "redesigned" individually, then in pairs or quartets. We computed the resulting binding free energy and vitality changes. Out of seven known resistance mutations involving active site positions, five were correctly recovered. Ten positions exhibited mutations with significant predicted vitality gains. Direct couplings between designed positions were predicted to be small, which reduces the combinatorial complexity of the mutation space to be explored. It also suggests that over the course of evolution, resistance mutations involving several positions do not need the underlying point mutations to arise all at once: they can appear and become fixed one after the other.
Identifiants
pubmed: 36699702
doi: 10.3389/fmolb.2022.905588
pii: 905588
pmc: PMC9868620
doi:
Types de publication
Journal Article
Langues
eng
Pagination
905588Informations de copyright
Copyright © 2023 Michael, Saint-Jalme, Mignon and Simonson.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nature. 1995 Apr 6;374(6522):569-71
pubmed: 7700387
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14115-20
pubmed: 21831831
Elife. 2020 Jul 23;9:
pubmed: 32701056
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18225-30
pubmed: 25453083
Rep Prog Phys. 2019 Jan;82(1):016601
pubmed: 30270850
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
Nat Commun. 2021 May 19;12(1):2949
pubmed: 34011959
Angew Chem Int Ed Engl. 2008;47(4):697-700
pubmed: 18058968
Biochemistry. 1997 Jan 21;36(3):586-603
pubmed: 9012674
Rep Prog Phys. 2018 Mar;81(3):032601
pubmed: 29120346
Biochemistry. 1995 Jul 25;34(29):9282-7
pubmed: 7626598
J Phys Chem A. 2020 Dec 24;124(51):10637-10648
pubmed: 33170681
PLoS Comput Biol. 2020 Jan 9;16(1):e1007600
pubmed: 31917825
J Comput Chem. 2014 Jul 5;35(18):1371-87
pubmed: 24854675
Nat Methods. 2020 Jul;17(7):665-680
pubmed: 32483333
Annu Rev Biophys. 2008;37:153-73
pubmed: 18573077
J Comput Chem. 2017 Nov 5;38(29):2509-2519
pubmed: 28786118
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28396541
Curr Opin Struct Biol. 2022 Feb;72:46-54
pubmed: 34461593
mBio. 2017 Sep 5;8(5):
pubmed: 28874476
J Phys Chem B. 2017 Jul 20;121(28):6831-6840
pubmed: 28635289
J Chem Phys. 2018 Aug 21;149(7):072302
pubmed: 30134674
J Biomol Struct Dyn. 1991 Jun;8(6):1267-89
pubmed: 1892586
Proteins. 2012 Apr;80(4):1110-22
pubmed: 22275047